We’re delighted to invite you to the RNA Vaccines & Therapeutics Conference London, taking place on 15-16 September 2026, at BMA House, London. Hosted by CPI , Imperial College London , and the BioIndustry Association (BIA) , this leading conference will bring together experts from academia, biotech, pharma, and government to explore the developments shaping the next generation of RNA medicines. As RNA technologies continue to advance, collaboration across the innovation ecosystem is essential to translate scientific discoveries into real-world solutions. The conference provides a forum to share knowledge, build partnerships, and discuss the priorities that will drive the field forward. Over two days, attendees will gain insights into advances in RNA vaccines and therapeutics, explore challenges in manufacturing, delivery, and scale-up, and connect with peers from across the RNA ecosystem. Featured speakers We are excited to announce a line-up of expert speakers, including: William Schief, Vice-President Protein Design, Moderna. Norbert Pardi, Associate Professor at University of Pennsylvania Perelman School of Medicine. Karin Lore, Professor, Center for Molecular Medicine at the Karolinska Institutet, Stockholm. Saranya Sridhar, VP, Head of Global Clinical Development, Vaccines, Sanofi. In addition to an outstanding programme of invited speakers, the conference will feature presentations and poster sessions selected through our abstract submission process, showcasing emerging research and innovative applications from across the RNA ecosystem. Call for abstracts We are now inviting researchers, scientists, innovators, and industry professionals to submit abstracts for oral and poster presentations. This is an excellent opportunity to share your latest work, gain visibility among key stakeholders, and contribute to discussions shaping the future of RNA-based medicines. Whether you are advancing novel RNA technologies, developing therapeutic applications, or exploring

Description supplied by the event organiser.